Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
342
-
Total 13F shares, excl. options
-
28.3M
-
Shares change
-
-762K
-
Total reported value, excl. options
-
$4.22B
-
Value change
-
-$208M
-
Put/Call ratio
-
1.41
-
Number of buys
-
172
-
Number of sells
-
-194
-
Price
-
$149.10
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q3 2021
437 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q3 2021.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 342 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.3M shares
of 33M outstanding shares and own 85.75% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.88M shares), VANGUARD GROUP INC (3.22M shares), AMERIPRISE FINANCIAL INC (1.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.27M shares), RIVERBRIDGE PARTNERS LLC (1.01M shares), STATE STREET CORP (827K shares), JPMORGAN CHASE & CO (822K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (764K shares), WELLINGTON MANAGEMENT GROUP LLP (696K shares), and D. E. Shaw & Co., Inc. (653K shares).
This table shows the top 342 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.